Shares of Organigram Holdings Inc. (NASDAQ:OGI - Get Free Report) traded down 2.7% during mid-day trading on Monday . The company traded as low as $0.87 and last traded at $0.92. 836,493 shares were traded during mid-day trading, an increase of 5% from the average session volume of 799,625 shares. The stock had previously closed at $0.95.
Organigram Trading Up 6.2 %
The stock has a market capitalization of $130.04 million, a price-to-earnings ratio of -2.71 and a beta of 1.10. The firm has a 50-day moving average of $1.15 and a 200 day moving average of $1.45.
Organigram (NASDAQ:OGI - Get Free Report) last posted its quarterly earnings data on Tuesday, February 11th. The company reported ($0.05) EPS for the quarter, missing analysts' consensus estimates of ($0.03) by ($0.02). Organigram had a negative net margin of 31.69% and a negative return on equity of 8.59%. Equities research analysts predict that Organigram Holdings Inc. will post -0.19 EPS for the current fiscal year.
Hedge Funds Weigh In On Organigram
Large investors have recently made changes to their positions in the business. Toronto Dominion Bank raised its position in shares of Organigram by 803.7% during the third quarter. Toronto Dominion Bank now owns 16,727 shares of the company's stock worth $30,000 after purchasing an additional 14,876 shares during the period. Clear Harbor Asset Management LLC lifted its stake in Organigram by 37.4% in the fourth quarter. Clear Harbor Asset Management LLC now owns 45,000 shares of the company's stock valued at $72,000 after acquiring an additional 12,250 shares during the last quarter. Arrowstreet Capital Limited Partnership bought a new stake in Organigram in the fourth quarter worth $1,153,000. Tidal Investments LLC boosted its stake in shares of Organigram by 8.3% during the 3rd quarter. Tidal Investments LLC now owns 1,948,188 shares of the company's stock worth $3,526,000 after acquiring an additional 149,171 shares in the last quarter. Finally, Cubist Systematic Strategies LLC grew its holdings in Organigram by 210.7% during the fourth quarter. Cubist Systematic Strategies LLC now owns 45,095 shares of the company's stock valued at $73,000 after purchasing an additional 30,583 shares during the last quarter. Institutional investors own 34.63% of the company's stock.
About Organigram
(
Get Free Report)
Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.
Featured Stories
Before you consider Organigram, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Organigram wasn't on the list.
While Organigram currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
